|
1
|
Carmeliet P and Jain RK: Angiogenesis in
cancer and other diseases. Nature. 407:249–257. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bergers G and Benjamin LE: Tumorigenesis
and the angiogenic switch. Nat Rev Cancer. 3:401–410. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shinkaruk S, Bayle M, Laïn G and Déléris
G: Vascular endothelial cell growth factor (VEGF), an emerging
target for cancer chemotherapy. Curr Med Chem Anticancer Agents.
3:95–117. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferrara N: Vascular endothelial growth
factor: Basic science and clinical progress. Endocr Rev.
25:581–611. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hofstaetter JG, Saad FA, Samuel RE,
Wunderlich L, Choi YH and Glimcher MJ: Differential expression of
VEGF isoforms and receptors in knee joint menisci under systemic
hypoxia. Biochem Biophys Res Commun. 324:667–672. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shibuya M: Structure and function of
VEGF/VEGF-receptor system involved in angiogenesis. Cell Struct
Funct. 26:25–35. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ferrara N and Davis-Smyth T: The biology
of vascular endothelial growth factor. Endocr Rev. 18:4–25. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rmali K, Puntis M and Jiang W:
Tumour-associated angiogenesis in human colorectal cancer.
Colorectal Dis. 9:3–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schwartz JD, Rowinsky EK, Youssoufian H,
Pytowski B and Wu Y: Vascular endothelial growth factor receptor-1
in human cancer: Concise review and rationale for development of
IMC-18F1 (Human antibody targeting vascular endothelial growth
factor receptor-1). Cancer. 116:(Suppl 4). S1027–S1032. 2010.
View Article : Google Scholar
|
|
10
|
Shibuya M and Claesson-Welsh L: Signal
transduction by VEGF receptors in regulation of angiogenesis and
lymphangiogenesis. Exp Cell Res. 312:549–560. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wu Y, Hooper AT, Zhong Z, Witte L, Bohlen
P, Rafii S and Hicklin DJ: The vascular endothelial growth factor
receptor (VEGFR-1) supports growth and survival of human breast
carcinoma. Int J Cancer. 119:1519–1529. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lesslie DP, Summy JM, Parikh NU, Fan F,
Trevino JG, Sawyer TK, Metcalf CA, Shakespeare WC, Hicklin DJ,
Ellis LM and Gallick GE: Vascular endothelial growth factor
receptor-1 mediates migration of human colorectal carcinoma cells
by activation of Src family kinases. Br J Cancer. 94:1710–1717.
2006.PubMed/NCBI
|
|
13
|
Kaplan RN, Riba RD, Zacharoulis S, Bramley
AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, et
al: VEGFR1-positive haematopoietic bone marrow progenitors initiate
the pre-metastatic niche. Nature. 438:820–827. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaplan RN, Rafii S and Lyden D: Preparing
the ‘soil’: The premetastatic niche. Cancer Res. 66:11089–11093.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Handbook. 7th.
Springer; New York: 2010
|
|
16
|
Hamilton SR and Aaltonen LA: Pathology and
genetics of tumours of the digestive system. IARC Press; Lyon:
2000
|
|
17
|
Weidner N, Semple JP, Welch WR and Folkman
J: Tumor angiogenesis and metastasis-correlation in invasive breast
carcinoma. N Eng J Med. 324:1–8. 1991. View Article : Google Scholar
|
|
18
|
Giantonio BJ, Catalano PJ, Meropol NJ,
O'Dwyer PJ, Mitchell EP, Alberts SR, Schwartz MA and Benson AB III:
Eastern Cooperative Oncology Group Study E3200: Bevacizumab in
combination with oxaliplatin, fluorouracil, and leucovorin
(FOLFOX4) for previously treated metastatic colorectal cancer:
Results from the Eastern Cooperative Oncology Group Study E3200. J
Clin Oncol. 25:1539–1544. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Duff SE, Jeziorska M, Kumar S, Haboubi N,
Sherlocks D, O'Dwyer ST and Jayson GC: Lymphatic vessel density,
microvessel density and lymphangiogenic growth factor expression in
colorectal cancer. Colorectal Dis. 9:793–800. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Teranishi N, Naito Z, Ishiwata T, Tanaka
N, Furukawa K, Seya T, Shinji S and Tajiri T: Identification of
neovasculature using nestin in colorectal cancer. Int J Oncol.
30:593–603. 2007.PubMed/NCBI
|
|
21
|
Kitadai Y, Haruma K, Tokutomi T, Tanaka S,
Sumii K, Carvalho M, Kuwabara M, Yoshida K, Hirai T, Kajiyama G and
Tahara E: Significance of vessel count and vascular endothelial
growth factor in human esophageal carcinomas. Clin Cancer Res.
4:2195–2200. 1998.PubMed/NCBI
|
|
22
|
Xiangming C, Hokita S, Natsugoe S, Tanabe
G, Baba M, Takao S, Kuroshima K and Aikou T: Angiogenesis as an
unfavorable factor related to lymph node metastasis in early
gastric cancer. Ann Surg Oncol. 5:585–589. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Isozaki H, Okajima K, Kawashima Y, Yamada
S, Nakata E, Nishimura J and Ichinona T: Prognostic value of the
number of metastatic lymph nodes in gastric cancer with radical
surgery. J Surg Oncol. 53:247–251. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gallego M Galindo, Fernández Acenero MJ,
Ortega J Sanz and Aljama A: Vascular enumeration as a
prognosticator for colorectal carcinoma. Eur J Cancer. 36:55–60.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kaio E, Tanaka S, Kitadai Y, Sumii M,
Yoshihara M, Haruma K and Chayama K: Clinical significance of
angiogenic factor expression at the deepest invasive site of
advanced colorectal carcinoma. Oncology. 64:61–73. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang JT, Huang KC, Jeng YM, Lee PH, Lai
HS and Hsu HC: Microvessel density, cyclo-oxygenase 2 expression,
K-ras mutation and p53 overexpression in colonic cancer. Br J Surg.
91:355–361. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zheng S, Han MY, Xiao ZX, Peng JP and Dong
Q: Clinical significance of vascular endothelial growth factor
expression and neovascularization in colorectal carcinoma. World J
Gastroenterol. 9:1227–1230. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
White JD, Hewett PW, Kosuge D, McCulloch
T, Enholm BC, Carmichael J and Murray JC: Vascular endothelial
growth factor-D expression is an independent prognostic marker for
survival in colorectal carcinoma. Cancer Res. 62:1669–1675.
2002.PubMed/NCBI
|
|
29
|
Lindmark G, Gerdin B, Sundberg C, Pahlman
L, Bergström R and Glimelius B: Prognostic significance of the
microvascular count in colorectal cancer. J Clin Oncol. 14:461–466.
1996.PubMed/NCBI
|
|
30
|
Vermeulen P, Gasparini G, Fox SB, Toi M,
Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL
and Dirix LY: Quantification of angiogenesis in solid human
tumours: An international consensus on the methodology and criteria
of evaluation. Eur J Cancer. 32:2474–2484. 1996. View Article : Google Scholar
|
|
31
|
Weidner N: Intratumor microvessel density
as a prognostic factor in cancer. Am J Pathol. 147:9–19.
1995.PubMed/NCBI
|
|
32
|
Pusztaszeri MP, Seelentag W and Bosman FT:
Immunohistochemical expression of endothelial markers CD31, CD34,
Von Willebrand factor, and Fli-1 in normal human tissues. J
Histochem Cytochem. 54:385–395. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Duff SE, Li C, Garland JM and Kumar S:
CD105 is important for angiogenesis: Evidence and potential
applications. FASEB J. 17:984–992. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Des Guetz G, Uzzan B, Nicolas P, Cucherat
M, Morere JF, Benamouzig R, Breau JL and Perret GY: Microvessel
density and VEGF expression are prognostic factors in colorectal
cancer. Meta-analysis of the literature. Br J Cancer. 94:1823–1832.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tanigawa N, Amaya H, Matsumura M and
Shimomatsuya T: Correlation between expression of vascular
endothelial growth factor and tumor vascularity, and patient
outcome in human gastric carcinoma. J Clin Oncol. 15:826–832.
1997.PubMed/NCBI
|
|
36
|
Custodio A, Barriuso J, de Castro J,
Martínez-Marín V, Moreno V, Rodríguez-Salas N and Feliu J:
Molecular markers to predict outcome to antiangiogenic therapies in
colorectal cancer: Current evidence and future perspectives. Cancer
Treat Rev. 39:908–924. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kosaka Y, Mimori K, Fukagawa T, Ishikawa
K, Etoh T, Katai H, Sano T, Watanabe M, Sasako M and Mori M:
Identification of the high-risk group for metastasis of gastric
cancer cases by vascular endothelial growth factor receptor-1
overexpression in peripheral blood. Br J Cancer. 96:1723–1728.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Takahashi Y, Kitadai Y, Bucana CD, Cleary
KR and Ellis LM: Expression of vascular endothelial growth factor
and its receptor, KDR, correlates with vascularity, metastasis, and
proliferation of human colon cancer. Cancer Res. 55:3964–3968.
1995.PubMed/NCBI
|
|
39
|
Okita NT, Yamada Y, Takahari D, Hirashima
Y, Matsubara J, Kato K, Hamaguchi T, Shirao K, Shimada Y, Taniguchi
H and Shimoda T: Vascular endothelial growth factor receptor
expression as a prognostic marker for survival in colorectal
cancer. Jpn J Clin Oncol. 39:595–600. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ning Y, Lurje G, Danenberg K, Cooc J, Yang
D, Pohl A, Zhang W and Lenz H: VEGF and VEGFR1 gene expression
levels and tumor recurrence in adjuvant colon cancer. J Clin Oncol.
27:40402009.
|
